Cargando…
Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia (Adv. Sci. 26/2022)
Engineered T Cells In article number 2201883, Hong Nam Kim, Hee Ho Park, Wonhwa Lee, and co‐workers present chimeric T cells stably expressing therapeutic peptides for treatment of severe infectious diseases. Using lentiviral system, T cells are engineered to express multi‐level therapeutic peptides...
Autores principales: | Kim, Hyelim, Son, Boram, Seo, Eun U, Kwon, Miji, Ahn, June Hong, Shin, Heungsoo, Song, Gyu Yong, Park, Eun Ji, Na, Dong Hee, Cho, Seung‐Woo, Kim, Hong Nam, Park, Hee Ho, Lee, Wonhwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475514/ http://dx.doi.org/10.1002/advs.202270168 |
Ejemplares similares
-
Cleavage‐Responsive Biofactory T Cells Suppress Infectious Diseases‐Associated Hypercytokinemia
por: Kim, Hyelim, et al.
Publicado: (2022) -
A Zinc–Bromine Battery with Deep Eutectic Electrolytes (Adv. Sci. 36/2022)
por: Heo, Jiyun, et al.
Publicado: (2022) -
Ferroelectric Field‐Effect‐Transistor Integrated with Ferroelectrics Heterostructure (Adv. Sci. 21/2022)
por: Baek, Sungpyo, et al.
Publicado: (2022) -
Ocular Nanomedicine (Adv. Sci. 15/2022)
por: Tang, Zhimin, et al.
Publicado: (2022) -
Organic Anisotropic Excitonic Optical Nanoantennas (Adv. Sci. 23/2022)
por: Kang, Evan S. H., et al.
Publicado: (2022)